Evidence map›Paper›PMID 29915190›Full record

ArticleScientific reports2018

Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system.

Areumnuri Kim, Sehwan Shim, Min-Jung Kim, Jae Kyung Myung, Sunhoo Park

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Cell Therapies for Acute Radiation Syndrome.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Areumnuri KimLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Seoul, Korea.
Sehwan ShimLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Seoul, Korea.
Min-Jung KimLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Seoul, Korea.
Jae Kyung MyungLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Seoul, Korea.
Sunhoo ParkLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Seoul, Korea. sunhoo@kirams.re.kr.
National Emergency Management Agency · KRKorea Institute of Radiological and Medical Sciences · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation exposure severely damages the hematopoietic system. Although several radio-protectors have been proposed to prevent radiation-induced damage, most agents have limited efficacy. In the present study, we investigated whether mesenchymal stem cells (MSCs) could contribute to the expansion of hematopoietic cells and mitigate radiation-induced hematopoietic injury in vitro and in vivo. We found that co-culture with MSCs promoted hematopoietic progenitor/stem cell (HPSCs) maintenance by providing a bone marrow-like microenvironment. In addition, we showed that MSCs prevented radiation-induced damage to HPSCs, as evidenced by the lack of DNA damage and apoptosis. Intravenously injected MSCs rapidly migrated to the bone marrow (BM) and prevented loss of BM cellularity, which reduced lethality and ameliorated pancytopenia in the BM of whole body-irradiated mice. We demonstrated that MSC-derived Jagged1 attenuated radiation-induced cytotoxicity of HPSCs, and that this was mediated by Notch signaling and expression of downstream proteins Bcl2 and p63 in HPSCs. In addition, Notch2 depletion significantly reduced the MSC-mediated radio-protective effect in human- and mouse-derived HPSCs. Collectively, our data show that activation of Notch and its associated downstream signaling pathways prevent radiation-induced hematopoietic injury. Therefore, enhancing Jagged1-Notch2 signaling could provide therapeutic benefit by protecting the hematopoietic system against damage after radiation.

Indexed as

AnimalsApoptosisBone MarrowHematopoietic Stem CellsHumansMaleMesenchymal Stem CellsMice, Inbred C57BLRadiation InjuriesRadiation, IonizingReceptor, Notch2Serrate-Jagged ProteinsSignal TransductionTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor ProteinsReceptor, Notch2Serrate-Jagged ProteinsTP63 protein, humanTranscription FactorsTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID29915190
PMCPMC6006282
OpenAlexW2808235992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.